Çevik Gürel1, Ahmet İnanır2, Ayşe Feyda Nursal3, Akın Tekcan4, Aydın Rüstemoğlu1, Serbülent Yigit1. 1. Department of Medical Biology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey. 2. Department of Physical Medicine and Rehabilitation, Gaziosmanpaşa University School of Medicine, Tokat, Turkey. 3. Department of Medical Genetics, Giresun University, School of Medicine, Giresun, Turkey. 4. Ahi Evran University School of Health, Kırşehir, Turkey.
Abstract
BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the spine and sacroiliac joints. Macrophage migration inhibitory (MIF) factor is a regulatory cytokine that inhibits random immune cell migration. MIF gene promoter polymorphisms play a role in the progression of several inflammatory disorders. AIMS: To investigate the relationship between the MIF gene -173 G/C single-nucleotide polymorphism (SNP) and AS. STUDY DESIGN: Cross-sectional study. METHODS: In this study, a total of 161 AS and 194 normal controls were recruited. The MIF gene -173 G/C SNP was analyzed by polymerase chain reaction using the restriction fragment length polymorphism method. RESULTS: There was no significant difference between groups in terms of genotype distribution (p>0.05). When wild-type G/G and G/C+C/C genotypes are compared in terms of clinical characteristics, there is a significant difference between the average age and the duration of disease in AS patients (p<0.05). CONCLUSION: No significant relationship between AS disease and MIF -173 G/C polymorphism was found. MIF -173 G/C polymorphism (C allele) may affect the time of onset and the duration of disease in AS patients.
BACKGROUND:Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the spine and sacroiliac joints. Macrophage migration inhibitory (MIF) factor is a regulatory cytokine that inhibits random immune cell migration. MIF gene promoter polymorphisms play a role in the progression of several inflammatory disorders. AIMS: To investigate the relationship between the MIF gene -173 G/C single-nucleotide polymorphism (SNP) and AS. STUDY DESIGN: Cross-sectional study. METHODS: In this study, a total of 161 AS and 194 normal controls were recruited. The MIF gene -173 G/C SNP was analyzed by polymerase chain reaction using the restriction fragment length polymorphism method. RESULTS: There was no significant difference between groups in terms of genotype distribution (p>0.05). When wild-type G/G and G/C+C/C genotypes are compared in terms of clinical characteristics, there is a significant difference between the average age and the duration of disease in AS patients (p<0.05). CONCLUSION: No significant relationship between AS disease and MIF-173 G/C polymorphism was found. MIF-173 G/C polymorphism (C allele) may affect the time of onset and the duration of disease in AS patients.
Authors: Esen Kasapoglu Gunal; Fatma Oguz Sarvan; Sevil Kamali; Ahmet Gul; Murat Inanc; Mahmut Carin; Meral Konice; Orhan Aral; Lale Ocal Journal: Joint Bone Spine Date: 2008-04-18 Impact factor: 4.929
Authors: M A Llamas-Covarrubias; Y Valle; R Bucala; R E Navarro-Hernández; C A Palafox-Sánchez; J R Padilla-Gutiérrez; I Parra-Rojas; A G Bernard-Medina; Z Reyes-Castillo; J F Muñoz-Valle Journal: Cytokine Date: 2013-02-09 Impact factor: 3.861
Authors: Fang-Fang Wang; Xin-Fang Huang; Nan Shen; Lin Leng; Richard Bucala; Shun-Le Chen; Liang-Jing Lu Journal: Arthritis Res Ther Date: 2013 Impact factor: 5.156